Knee replacement bandaging study (KReBS)

Phase 3

Completed

• Conditions: Specialty: Musculoskeletal disorders, Primary sub-specialty: Elective Orthopaedic Surgery; UKCRC code/ Disease: Musculoskeletal/ Other joint disorders; Musculoskeletal Diseases; Knee arthritis/total knee replacement

• Registration Number: ISRCTN87127065
• Lead Sponsor: orthumbria Healthcare NHS Foundation Trust

Brief Summary

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31068223 protocol (added 10/05/2019) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/35600143/ An embedded randomised controlled retention trial of personalised text messages compared to non-personalised text messages in an orthopaedic setting (added 31/10/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-02-20
• Study Completion: 2020-11-07
• Last Update Posted: 14 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 2338

Inclusion Criteria

1. Patients scheduled for primary total knee arthroplasty
2. Presenting at a participating trial site
3. Aged over 18
4. Able to provide written informed consent

Exclusion Criteria

1. Unable to consent
2. History of peripheral vascular disease
3. History of peripheral neuropathy
4. History of, or current venous ulceration
5. Absent foot pulses
6. Planned same day discharge joint replacement patients
7. Revision knee arthroplasty
8. Unicondylar or patellofemoral joint knee arthroplasty
9. Regular concomitant high dose anti-coagulant medication. Patients on routine thromboprophylaxis can be included
10. Unwilling to provide informed consent
11. Lack mental capacity and therefore unlikely to comply with data collection

Study & Design

• Study Type: Interventional
• Study Design: Not specified